Stock Price Targets and Analyst Ratings

Stay on top of the latest U.S. and international stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view the companies you follow. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

On This Page:About Stock Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAF Airtel Africa	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 348.43 -0.6%	GBX 450 ➝ GBX 450	Buy
AAL American Airlines Group	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Didora Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.25 +1.6%	$14.00 ➝ $16.00	Neutral
AAL American Airlines Group	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Godyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.25 +1.6%		Neutral
AAOI Applied Optoelectronics	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Genovese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$169.33 +4.6%	$220.00	Buy
AAPL Apple	Downgraded by	KGI Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$299.14 +0.4%	$315.00	Outperform ➝ Hold
ABBV AbbVie	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$229.41 +6.0%	$260.00
ABT Abbott Laboratories	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Maeder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.00 -0.5%	$115.00	Overweight
ACHV Achieve Life Sciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.09 +4.8%	$12.00	Buy
ACN Accenture	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.68 -7.3%	$177.00 ➝ $130.00	Equal Weight
ACN Accenture	Target Lowered by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$118.68 -7.3%	$335.00 ➝ $220.00	Buy
Buy this stock today (Ad) Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. Get the name, ticker, and full Hotlist before markets open
ACN Accenture	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$118.68 -7.3%	$199.00 ➝ $140.00	Hold
ACN Accenture	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Bergin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.68 -7.3%	$258.00 ➝ $150.00	Buy ➝ Hold
ACN Accenture	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kupferberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.68 -7.3%		Overweight
ACN Accenture	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.68 -7.3%	$225.00 ➝ $185.00	Buy
ACN Accenture	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.68 -7.3%	$225.00 ➝ $185.00	Buy
ACN Accenture	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Friedman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.68 -7.3%	$186.00 ➝ $140.00	Neutral
ACN Accenture	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.68 -7.3%	$253.00 ➝ $175.00	Outperform
ACN Accenture	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arvind Ramnani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.68 -7.3%	$210.00 ➝ $150.00	Hold
AFLYY Air France-KLM	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.34 -4.6%		Hold
AFYA Afya	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marcelo Santos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.29 +1.6%	$21.50 ➝ $21.00	Neutral
AGI Alamos Gold	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harmen Puri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.68 -12.8%	$57.00 ➝ $50.00	Buy
AGMB AgomAb Therapeutics	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.05 +9.7%	$35.00	Buy
AIZ Assurant	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Newsome Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$262.06 +0.8%		Overweight
ALGM Allegro MicroSystems	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Buchalter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.86 +3.1%	$55.00 ➝ $70.00	Buy
ALIT Alight	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Heckmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.55 -2.7%	$2.00	Buy
ALKS Alkermes	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Thome Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.02 +2.3%	$42.00 ➝ $50.00	Buy
ALKT Alkami Technology	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ella Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.47 -1.5%	$20.00 ➝ $19.00	Overweight
ALT Altimmune	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.92 +8.0%	$10.00	Outperform
AMAT Applied Materials	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$624.06 +1.1%	$520.00 ➝ $715.00	Overweight
AMRZ Amrize	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$52.96 -4.3%		Outperform
AMRZ Amrize	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$52.96 -4.3%	$63.00	Overweight
ANL Adlai Nortye	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Li Watsek Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.59 +4.9%		Overweight
APA APA	Upgraded by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Mariani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.16 +3.4%	$37.00 ➝ $38.00	Neutral ➝ Buy
APGE Apogee Therapeutics	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Nash Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$132.63 +46.7%	$130.00 ➝ $135.11	Buy ➝ Hold
APGE Apogee Therapeutics	Downgraded by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$132.63 +46.7%		Outperform ➝ Neutral
APGE Apogee Therapeutics	Target Set by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$132.63 +46.7%	$135.11	Buy ➝ Hold
APP AppLovin	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bazinet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$462.58 -1.5%		Buy
ARMK Aramark	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Carrington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.73 +0.8%	$63.00 ➝ $70.50	Buy
ASML ASML	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,890.50 -2.0%	$1,750.00 ➝ $2,200.00	Overweight
ASML ASML	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Didier Scemama Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,890.50 -2.0%	$2,268.00 ➝ $2,345.00	Buy
Trump Is Eyeing the Biggest Monetary Shift Since Nixon (Ad) On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that night, the dollar has lost over 85% of its purchasing power - and retirement savers have absorbed the cost. U.S. Code Title 31, Section 5117 gives the Treasury authority to reprice America's gold reserves from $42 per ounce to today's market value - a gap of 107x. More than 60 million Americans can move into physical gold inside a retirement account, tax-free and penalty-free. Download the free 2026 Gold Guide to see how it works
BAB Babcock International Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 984.40 -5.9%	GBX 1,400 ➝ GBX 1,400	Buy
BBOT BridgeBio Oncology Therapeutics	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mazahir Alimohamed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.81 +3.2%	$22.00	Outperform
BBY Best Buy	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$76.57 +2.5%		Sector Weight
BBY Best Buy	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.57 +2.5%	$90.00	Buy
BE Bloom Energy	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$340.38 +3.5%	$322.00
BEN Franklin Resources	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Katz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.92 +2.6%	$37.00 ➝ $40.00	Buy
BHP BHP Group	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Fairclough Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.74 -2.4%	$93.00 ➝ $91.00	Neutral
BIIB Biogen	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$198.03 +0.7%		Overweight
BILL BILL	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jared Levine Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.70 -2.4%	$43.00	Buy
BMRN BioMarin Pharmaceutical	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.63 +1.7%		Neutral
BPOP Popular	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manuel Navas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.54 +2.1%		Overweight
BR Broadridge Financial Solutions	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$134.39 -2.3%	$200.00	Outperform
BROS Dutch Bros	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.34 -4.8%	$75.00 ➝ $90.00	Buy
BROS Dutch Bros	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Mullan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.34 -4.8%	$61.00 ➝ $68.00	Neutral
BTGO BTGO	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Knoblauch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.96 -0.2%		Overweight
BTSG BrightSpring Health Services	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.29 +1.6%	$65.00 ➝ $90.00	Buy
BVC BATM Advanced Communications	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 15.20 +6.3%		House Stock
BWIN Baldwin Insurance Group	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pablo Singzon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.55 +16.4%	$25.00 ➝ $28.00	Neutral ➝ Overweight
BWIN Baldwin Insurance Group	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.55 +16.4%	$28.00
BYD Boyd Gaming	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Hickey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.43 +2.1%	$100.00	Buy
CASY Casey's General Stores	Initiated by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$831.87 -1.2%	$896.00	Equal Weight
CBOE Cboe Global Markets	Target Set by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$257.30 +3.3%	$263.00
CCOI Cogent Communications	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Williams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.81 +4.3%		Buy
CGTX Cognition Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.64 +12.8%	$3.00	Buy
CIZN Citizens	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.25 -1.3%		Market Outperform
CLF Cleveland-Cliffs	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carlos De Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.83 -3.7%	$12.00 ➝ $12.50	Overweight ➝ Equal Weight
CMC Commercial Metals	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carlos De Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.52 +0.2%	$83.00 ➝ $88.00	Overweight
CME CME Group	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$245.01 -0.6%	$323.00 ➝ $273.00	Buy
CNXC Concentrix	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vincent Colicchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.98 -4.4%	$38.00	Outperform
CNXU Conexeu Sciences	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.23 -7.9%	$20.00	Buy
COP ConocoPhillips	Upgraded by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Mariani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.63 +1.8%	$124.00 ➝ $130.00	Neutral ➝ Buy
COP ConocoPhillips	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$109.63 +1.8%	$130.00
CRDO Credo Technology Group	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tore Svanberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$300.36 +10.5%	$250.00 ➝ $350.00	Buy
CRDO Credo Technology Group	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$300.36 +10.5%	$325.00	Outperform
CURB Curbline Properties	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Todd M. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.48 +2.1%	$30.00 ➝ $32.00	Overweight
CVS CVS Health	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$101.56 +3.3%		Buy
DAL Delta Air Lines	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Godyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.15 +2.3%		Buy
DAL Delta Air Lines	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$86.15 +2.3%	$85.00 ➝ $100.00	Buy
DAL Delta Air Lines	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Didora Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.15 +2.3%	$78.00 ➝ $93.00	Buy
DAR Darling Ingredients	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$53.04 -1.2%	$58.00	Equal Weight
DAR Darling Ingredients	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.04 -1.2%	$58.00	Equal Weight
DASH DoorDash	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Josey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$172.60 -0.5%		Market Outperform
DCH American Axle & Manufacturing	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Levy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.15 -2.6%	$8.00	Equal Weight
DFTX Definium Therapeutics	Target Set by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marc Goodman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.87 +54.7%	$30.00 ➝ $52.00	Outperform
DFTX Definium Therapeutics	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.87 +54.7%		Outperform
DFTX Definium Therapeutics	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Olson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.87 +54.7%	$40.00 ➝ $60.00	Outperform
DKNG DraftKings	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.89 -1.9%		Buy
DKNG DraftKings	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.89 -1.9%		Market Outperform
DKNG DraftKings	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.89 -1.9%	$34.00	Market Outperform
DNLI Denali Therapeutics	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.02 +3.0%		Hold
Stranded On The Flood Plains of History (Ad) The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar. Read Porter's full briefing and get the ticker names today
DNLI Denali Therapeutics	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Mattels Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.02 +3.0%	$41.00
DRI Darden Restaurants	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$209.86 -1.7%		Market Perform
DVN Devon Energy	Target Set by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Doug Leggate Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.99 +2.1%	$67.00	Outperform
EL Estee Lauder Companies	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bonnie Herzog Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.40 +0.7%	$100.00	Buy
EOG EOG Resources	Target Lowered by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$132.03 +1.6%	$186.00 ➝ $176.00	Strong-Buy
EQBK Equity Bancshares	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Rulis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.73 +0.3%	$47.00 ➝ $51.00	Neutral
EQBK Equity Bancshares	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nathan Race Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.73 +0.3%		Overweight
EQBK Equity Bancshares	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$46.73 +0.3%		Market Perform
EQBK Equity Bancshares	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$46.73 +0.3%		Buy
EQPT EquipmentShare.com	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Kimson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.22 -4.2%	$42.00	Market Outperform
EWG European Wealth Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 101.80 -0.9%	GBX 132 ➝ GBX 132	Buy
FANG Diamondback Energy	Target Set by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Mariani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$187.69 +2.3%	$212.00	Neutral ➝ Buy
FANG Diamondback Energy	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hanwen Chang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$187.69 +2.3%	$212.00
FDX FedEx	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$327.50 +0.4%		Buy
FDX FedEx	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bruce Chan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$327.50 +0.4%	$442.00
FMC FMC	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.95 -5.2%	$17.00 ➝ $14.00	Neutral
FPLSF 5N Plus	Initiated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$28.61 -2.5%		Outperform
FPS Forgent Power Solutions	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Elias Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.18 -3.5%	$63.00 ➝ $73.00	Buy
FTH Sensei Biotherapeutics	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.96 +28.8%	$60.00	Buy
GFM Griffin Mining	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 319 -1.8%	GBX 360 ➝ GBX 360	Buy
GLW Corning	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Niknam Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$207.88 +6.6%	$149.00 ➝ $205.00	Hold
GOOG Alphabet	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$347.56 -5.4%		Market Outperform
GPE Great Portland Estates	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 318.20 -1.2%	GBX 377 ➝ GBX 360	Hold
GPN Global Payments	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$65.40 -2.2%	$65.00	Overweight ➝ Equal Weight
HCA HCA Healthcare	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$375.85 +0.2%	$500.00 ➝ $431.00	Buy
HIK Hikma Pharmaceuticals	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,472.80 +1.1%	GBX 195 ➝ GBX 195	Buy
HUT Hut 8	Target Set by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$119.79 -3.7%	$226.00
ICE Intercontinental Exchange	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Katz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.09 -2.1%	$193.00 ➝ $153.00	Buy
IMAX IMAX	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Hickey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.28 -0.1%		Buy
INCY Incyte	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Evan Seigerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.05 +4.9%	$75.00 ➝ $94.00	Underperform ➝ Market Perform
INCY Incyte	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srikripa Devarakonda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.05 +4.9%	$103.00 ➝ $105.00	Hold
IONQ IonQ	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nehal Chokshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.21 +4.7%	$55.00 ➝ $70.00	Outperform
IRTC iRhythm Technologies	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Thibault Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.03 +0.4%	$185.00	Buy
JETMF Global Crossing Airlines Group	Initiated by	Litchfield Hills Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$0.67 -8.5%		Buy
KIM Kimco Realty	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Rosivach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.86 +1.9%	$28.00	Peer Perform ➝ Outperform
KLAC KLA	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$265.82 +2.4%	$210.00 ➝ $305.00	Overweight
KR Kroger	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.69 -1.6%	$58.00
KR Kroger	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.69 -1.6%	$78.00 ➝ $71.00	Buy
KR Kroger	Target Set by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.69 -1.6%	$78.00 ➝ $71.00	Buy
KR Kroger	Target Set by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.69 -1.6%	$82.00 ➝ $78.00	Outperform
KR Kroger	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.69 -1.6%	$70.00 ➝ $63.00	Neutral
KR Kroger	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.69 -1.6%	$73.00 ➝ $67.00	Equal Weight
KR Kroger	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Sigman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.69 -1.6%	$68.00 ➝ $61.00	Equal Weight
LBRX LB Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.61 -1.3%		Buy
LEU Centrus Energy	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Reagor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$182.68 -4.5%	$230.00 ➝ $195.00	Neutral
LGN LGN	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Seiden Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$89.92 +5.1%	$60.00 ➝ $80.00	Equal Weight
LIF Life360	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wyatt Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.65 -0.8%	$40.00 ➝ $42.00	Neutral
LIVN LivaNova	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Fishbin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.96 +0.6%	$83.00 ➝ $92.00	Overweight
LLY Eli Lilly and Company	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,103.32 +0.4%	$1,050.00 ➝ $1,135.00	Hold
LLY Eli Lilly and Company	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carter Gould Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,103.32 +0.4%		Overweight
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock (Ad) The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into MP Materials. The stock popped 200%. It bought 10% of Trilogy Metals. The stock popped 500%. And now, Trump has chosen this AI stock for a $1 billion payday. Click here for the full story and stock pick (free). Click here to get Louis Navellier's full analysis and his free pick
LODE Comstock	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.54 -4.9%		Reduce
LQDA Liquidia	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.05 +7.0%	$59.00 ➝ $109.00	Buy
LRCX Lam Research	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$396.29 +1.9%	$365.00 ➝ $450.00	Overweight
M Macy's	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Oliver Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.67 +2.2%	$20.00 ➝ $25.00	Hold
MAU Montage Gold	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$16.51 -0.8%	C$18.50 ➝ C$19.00	Sector Outperform
MCD McDonald's	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$270.86 -2.8%		Market Perform
MDA MDA Space	Reiterated by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.68 +0.7%		Outperform
MDA MDA Space	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.68 +0.7%		Outperform
MDA MDA Space	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$56.13 -5.0%	C$53.00 ➝ C$68.00	Outperform
MDA MDA Space	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$56.13 -5.0%	C$66.00 ➝ C$70.00	Buy
MDA MDA Space	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$56.13 -5.0%	C$70.00 ➝ C$75.00	Buy
MDA MDA Space	Target Lowered by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$56.13 -5.0%	C$67.00 ➝ C$62.00	Sector Perform
MDA MDA Space	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$56.13 -5.0%	C$56.00 ➝ C$65.00	Buy
MDA MDA Space	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$56.13 -5.0%	C$70.00 ➝ C$71.00	Sector Outperform
MEQ Mainstreet Equity	Target Lowered by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$168.21 +0.0%	C$245.00 ➝ C$225.00	Outperform
MGY Magnolia Oil & Gas	Upgraded by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Mariani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.08 +2.5%	$31.00	Neutral ➝ Buy
MLCO Melco Resorts & Entertainment	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Praveen Choudhary Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.32 -3.9%		Overweight ➝ Negative
MLCO Melco Resorts & Entertainment	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Praveen Choudhary Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.32 -3.9%	$6.30 ➝ $6.00	Overweight ➝ Equal Weight
MOD Modine Manufacturing	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Summerville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$292.04 -1.8%	$330.00	Buy
MPLT Maplight Therapeutics	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.34 +5.3%	$37.00 ➝ $42.00	Buy
MPLT Maplight Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.34 +5.3%		Buy
MPLT Maplight Therapeutics	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$30.34 +5.3%		Buy
MTDR Matador Resources	Upgraded by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Mariani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.43 +1.8%	$65.00	Neutral ➝ Buy
MTY MTY Food Group	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$36.46 -7.0%	C$49.00	Outperform
MU Micron Technology	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,188.85 +4.8%	$500.00 ➝ $1,550.00	Buy
MU Micron Technology	Target Set by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,188.85 +4.8%	$1,300.00
MUSA Murphy USA	Initiated by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$553.14 +0.3%	$710.00	Overweight
NCNO nCino	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.55 -1.7%		Market Outperform
NCNO nCino	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ella Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.55 -1.7%	$16.00 ➝ $17.00	Neutral
NDAQ Nasdaq	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Katz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.34 +0.1%	$104.00 ➝ $98.00	Buy
NRC National Research	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Constantine Davides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.16 +3.3%	$23.00	Market Outperform
NUE Nucor	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carlos De Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$241.78 -0.8%	$227.00 ➝ $258.00	Equal Weight
NVCT Nuvectis Pharma	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.15 +16.8%	$13.00 ➝ $39.00	Buy
OMDA Omada Health	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Hettenbach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.95 +1.8%	$30.00	Overweight
ONTO Onto Innovation	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Yang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.66 +2.7%	$370.00 ➝ $450.00	Outperform
OVV Ovintiv	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hanwen Chang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.23 +3.5%	$57.00 ➝ $80.00	Equal Weight ➝ Overweight
OVV Ovintiv	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.23 +3.5%	$70.00	Outperform
OWLT Owlet	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonna Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.04 +0.8%	$13.00 ➝ $10.00	Buy
PGNY Progyny	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jailendra Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.44 +1.4%	$30.00 ➝ $33.00	Buy
PGPHF Partners Group	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$835.00 -2.7%		Neutral
PINS Pinterest	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Blackledge Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.39 -4.3%		Buy
PLXS Plexus	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruben Roy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$303.27 +1.1%	$280.00 ➝ $330.00	Buy
PR Permian Resources	Target Set by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Mariani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.96 +2.9%	$23.00	Neutral ➝ Buy
PRME Prime Medicine	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.40 +5.1%		Market Outperform
PRME Prime Medicine	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.40 +5.1%	$6.00
PSA Public Storage	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldsmith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$319.59 +0.5%		Neutral
PXT Parex Resources	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$24.85 -5.0%	C$20.00 ➝ C$29.00	Sector Perform
PZG Paramount Gold Nevada	Reiterated by	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.24 -0.4%		Buy
QCOM Qualcomm	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$221.64 -2.0%	$150.00 ➝ $200.00	Neutral
QCOM Qualcomm	Target Set by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$221.64 -2.0%	$200.00
Stranded On The Flood Plains of History (Ad) The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar. Read Porter's full briefing and get the ticker names today
QTWO Q2	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ella Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.71 -2.7%	$80.00 ➝ $60.00	Overweight
RCL Royal Caribbean Cruises	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trey Bowers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$308.03 -1.4%	$360.00 ➝ $361.00	Overweight
RGNX REGENXBIO	Target Raised by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mani Foroohar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.20 +17.9%	$17.00 ➝ $18.00	Outperform
RGNX REGENXBIO	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Skorney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.20 +17.9%	$27.00 ➝ $32.00	Outperform
RMD ResMed	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Fishbin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$188.24 -0.2%	$290.00 ➝ $266.00	Overweight
RNMBY Rheinmetall	Upgraded by	Oddo Bhf Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$271.49 +0.5%		Outperform
RYAAY Ryanair	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$62.90 +2.7%		Overweight
SBCF Seacoast Banking Corporation of Florida	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Scouten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.23 +1.3%	$32.50 ➝ $34.00	Neutral
SCHYY Sands China	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.37 -2.3%		Overweight ➝ Equal Weight
SDLF Standard Life	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 818.45 +1.5%	GBX 950 ➝ GBX 975	Overweight
SIMO Silicon Motion Technology	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Bryson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$336.74 +4.7%	$230.00 ➝ $400.00	Outperform
SITE SiteOne Landscape Supply	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	W. Andrew Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.70 -2.2%	$157.00 ➝ $153.00	Buy
SM SM Energy	Upgraded by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Mariani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.40 +0.9%	$30.00 ➝ $32.00	Neutral ➝ Buy
SMTC Semtech	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Buchalter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$174.31 +10.2%	$210.00 ➝ $215.00	Buy
SNOW Snowflake	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$226.30 -2.6%		Buy
SO Southern	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$93.89 +0.9%	$99.00
SOHO Triple Point Social Housing REIT	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 74.45 -0.5%	GBX 82 ➝ GBX 82	Buy
SPCX SpaceX	Downgraded by	KGI Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$159.43 -13.8%		Outperform ➝ Hold
SPCX SpaceX	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$159.43 -13.8%		Negative
SPCX SpaceX	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$159.43 -13.8%		Buy
SPCX SpaceX	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$159.43 -13.8%		Underweight ➝ Overweight
SPCX SpaceX	Upgraded by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$159.43 -13.8%		Buy
SPCX SpaceX	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$159.43 -13.8%		Buy
SPCX SpaceX	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$159.43 -13.8%		Overweight
SPCX SpaceX	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Leshock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$159.43 -13.8%		Sector Weight
STLD Steel Dynamics	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carlos De Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$249.57 -0.1%	$227.00 ➝ $270.00	Equal Weight
STX Seagate Technology	Downgraded by	Fox Advisors Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,088.85 +1.7%		Overweight ➝ Equal Weight
SUNB Sunbelt Rentals Holdings, Inc. Common Stock	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Rose Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.58 -4.0%	$82.00 ➝ $90.00	Overweight
SVNLY Svenska Handelsbanken Ab Publ	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.34 +0.3%		Underweight
SXT Sensient Technologies	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.76 +4.6%		Buy
TEL TE Connectivity	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$211.82 -2.7%	$230.00	Outperform ➝ In-Line
TENX Tenax Therapeutics	Initiated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gautam Chukka Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.10 +0.8%	$27.00	Buy
TENX Tenax Therapeutics	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seamus Fernandez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.10 +0.8%	$34.00 ➝ $40.00	Buy
THC Tenet Healthcare	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$177.10 +2.6%	$242.00 ➝ $233.00	Buy
TIMB TIM	Upgraded by	Santander Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.44 +3.5%		Neutral ➝ Outperform
TMUS T-Mobile US	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Hodulik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$180.61 -0.6%	$300.00 ➝ $255.00	Buy
TREX Trex	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Hughes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.59 -1.1%	$50.00 ➝ $55.00	Buy
TSCO Tractor Supply	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.72 -1.7%	$45.00 ➝ $43.00	Buy
TSCO Tractor Supply	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.72 -1.7%	$50.00 ➝ $40.00	Buy
TSLA Tesla	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$406.24 +1.4%	$350.00 ➝ $375.00	Hold
TSM Taiwan Semiconductor Manufacturing	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mehdi Hosseini Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$466.04 +0.8%	$500.00 ➝ $575.00	Positive
TVTX Travere Therapeutics	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Chico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.66 +0.9%	$55.00 ➝ $61.00	Outperform
UAL United Airlines	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Didora Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$119.05 +0.6%	$140.00 ➝ $145.00	Buy
UAL United Airlines	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Godyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$119.05 +0.6%		Buy
UBER Uber Technologies	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$71.54 -0.1%		Market Outperform
UHS Universal Health Services	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$142.11 +0.7%	$230.00 ➝ $197.00	Buy
UNH UnitedHealth Group	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$408.08 +1.8%		Buy
UUUU Energy Fuels	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.37 -1.1%	$29.00	Buy
VC Visteon	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$119.52 +5.0%		Buy
VC Visteon	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rajat Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$119.52 +5.0%	$108.00 ➝ $165.00	Neutral ➝ Overweight
VC Visteon	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Levy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$119.52 +5.0%	$115.00 ➝ $145.00	Equal Weight ➝ Overweight
VICR Vicor	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shannon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$362.93 +9.5%	$450.00	Buy
VICR Vicor	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$362.93 +9.5%	$400.00	Buy
VICR Vicor	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Justin Clare Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$362.93 +9.5%	$285.00 ➝ $375.00	Buy
VNP 5N Plus	Target Set by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$41.29 -5.9%	C$48.00	Sector Outperform
WDC Western Digital	Downgraded by	Fox Advisors Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$732.37 -1.9%		Overweight ➝ Equal Weight
WHR Whirlpool	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rafe Jadrosich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.46 -3.6%	$43.00 ➝ $36.00	Underperform
WISE Wise	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 826.26 +1.0%	GBX 1,299 ➝ GBX 1,299	Buy
WMS Advanced Drainage Systems	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Hammond Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.97 -4.2%		Overweight
WTB Whitbread	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,462 +3.4%	GBX 2,280 ➝ GBX 2,280	Hold
XPER Xperi	Reiterated by	BWS Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hamed Khorsand Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.90 -0.5%	$12.00	Buy
XPS XPS Pensions Group	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 306 -3.5%	GBX 465 ➝ GBX 430	Outperform
ZBRA Zebra Technologies	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Guy Hardwick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$244.65 +3.7%	$345.00 ➝ $346.00	Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:24 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings